Table of Contents

1 Report Overview

• 1.1 Study Scope
• 1.2 Major Manufacturers Covered in This Report
• 1.3 Market Segment by Type
  • 1.3.1 Global Oxytocic Pharmaceuticals Market Size Growth Rate by Type (2019-2025)
  • 1.3.2 Natural Oxytocin
  • 1.3.3 Synthetic Oxytocin Derivative
• 1.4 Market Segment by Application
  • 1.4.1 Global Oxytocic Pharmaceuticals Market Share by Application (2019-2025)
  • 1.4.2 Abortion Induced Incomplete
  • 1.4.3 Inevitable Abortion
  • 1.4.4 Post-partum Haemorrhage
  • 1.4.5 Labour Induction
  • 1.4.6 Labour Arrest
• 1.5 Study Objectives
• 1.6 Years Considered

2 Global Growth Trends

• 2.1 Global Oxytocic Pharmaceuticals Market Size
  • 2.1.1 Global Oxytocic Pharmaceuticals Revenue 2014-2025
  • 2.1.2 Global Oxytocic Pharmaceuticals Sales 2014-2025
• 2.2 Oxytocic Pharmaceuticals Growth Rate by Regions
  • 2.2.1 Global Oxytocic Pharmaceuticals Sales by Regions 2014-2019
  • 2.2.2 Global Oxytocic Pharmaceuticals Revenue by Regions 2014-2019
• 2.3 Industry Trends
  • 2.3.1 Market Top Trends
  • 2.3.2 Market Drivers

3 Market Share by Manufacturers

• 3.1 Oxytocic Pharmaceuticals Sales by Manufacturers
  • 3.1.1 Oxytocic Pharmaceuticals Sales by Manufacturers 2014-2019
  • 3.1.2 Oxytocic Pharmaceuticals Sales Market Share by Manufacturers 2014-2019
• 3.2 Revenue by Manufacturers
  • 3.2.1 Oxytocic Pharmaceuticals Revenue by Manufacturers (2014-2019)
  • 3.2.2 Oxytocic Pharmaceuticals Revenue Share by Manufacturers (2014-2019)
  • 3.2.3 Global Oxytocic Pharmaceuticals Market Concentration Ratio (CR5 and HHI)
• 3.3 Oxytocic Pharmaceuticals Price by Manufacturers
• 3.4 Key Manufacturers Oxytocic Pharmaceuticals Plants/Factories Distribution and Area Served
• 3.5 Date of Key Manufacturers Enter into Oxytocic Pharmaceuticals Market
• 3.6 Key Manufacturers Oxytocic Pharmaceuticals Product Offered
• 3.7 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

• 4.1 Sales and Revenue for Each Type
  • 4.1.1 Natural Oxytocin Sales and Revenue (2014-2019)
  • 4.1.2 Synthetic Oxytocin Derivative Sales and Revenue (2014-2019)
• 4.2 Global Oxytocic Pharmaceuticals Sales Market Share by Type
• 4.3 Global Oxytocic Pharmaceuticals Revenue Market Share by Type
• 4.4 Oxytocic Pharmaceuticals Price by Type

5 Market Size by Application

• 5.1 Overview
• 5.2 Global Oxytocic Pharmaceuticals Sales by Application

6 United States

• 6.1 United States Oxytocic Pharmaceuticals Breakdown Data by Company
• 6.2 United States Oxytocic Pharmaceuticals Breakdown Data by Type
• 6.3 United States Oxytocic Pharmaceuticals Breakdown Data by Application

7 European Union

• 7.1 European Union Oxytocic Pharmaceuticals Breakdown Data by Company
• 7.2 European Union Oxytocic Pharmaceuticals Breakdown Data by Type
• 7.3 European Union Oxytocic Pharmaceuticals Breakdown Data by Application

8 China

• 8.1 China Oxytocic Pharmaceuticals Breakdown Data by Company
• 8.2 China Oxytocic Pharmaceuticals Breakdown Data by Type
• 8.3 China Oxytocic Pharmaceuticals Breakdown Data by Application

9 Rest of World

• 9.1 Rest of World Oxytocic Pharmaceuticals Breakdown Data by Company
• 9.2 Rest of World Oxytocic Pharmaceuticals Breakdown Data by Type
• 9.3 Rest of World Oxytocic Pharmaceuticals Breakdown Data by Application
• 9.4 Rest of World Oxytocic Pharmaceuticals Breakdown Data by Countries
  • 9.4.1 Rest of World Oxytocic Pharmaceuticals Sales by Countries
  • 9.4.2 Rest of World Oxytocic Pharmaceuticals Revenue by Countries
  • 9.4.3 Japan
  • 9.4.4 Korea
  • 9.4.5 India
  • 9.4.6 Southeast Asia

10 Company Profiles

• 10.1 Fresenius Kaci
  • 10.1.1 Fresenius Kaci Company Details
  • 10.1.2 Company Description and Business Overview
  • 10.1.3 Sales, Revenue and Market Share of Oxytocic Pharmaceuticals
  • 10.1.4 Oxytocic Pharmaceuticals Product Introduction
  • 10.1.5 Fresenius Kaci Recent Development
• 10.2 Biofutura
  • 10.2.1 Biofutura Company Details
  • 10.2.2 Company Description and Business Overview
  • 10.2.3 Sales, Revenue and Market Share of Oxytocic Pharmaceuticals
  • 10.2.4 Oxytocic Pharmaceuticals Product Introduction
  • 10.2.5 Biofutura Recent Development
• 10.3 Baxter
  • 10.3.1 Baxter Company Details
  • 10.3.2 Company Description and Business Overview
  • 10.3.3 Sales, Revenue and Market Share of Oxytocic Pharmaceuticals
  • 10.3.4 Oxytocic Pharmaceuticals Product Introduction
  • 10.3.5 Baxter Recent Development
• 10.4 Pfizer
  • 10.4.1 Pfizer Company Details
  • 10.4.2 Company Description and Business Overview
  • 10.4.3 Sales, Revenue and Market Share of Oxytocic Pharmaceuticals
  • 10.4.4 Oxytocic Pharmaceuticals Product Introduction
  • 10.4.5 Pfizer Recent Development
• 10.5 Ferring
  • 10.5.1 Ferring Company Details
  • 10.5.2 Company Description and Business Overview
  • 10.5.3 Sales, Revenue and Market Share of Oxytocic Pharmaceuticals
  • 10.5.4 Oxytocic Pharmaceuticals Product Introduction
  • 10.5.5 Ferring Recent Development
• 10.6 Novartis
  • 10.6.1 Novartis Company Details
  • 10.6.2 Company Description and Business Overview
  • 10.6.3 Sales, Revenue and Market Share of Oxytocic Pharmaceuticals
  • 10.6.4 Oxytocic Pharmaceuticals Product Introduction
  • 10.6.5 Novartis Recent Development
• 10.7 Teva
  • 10.7.1 Teva Company Details
  • 10.7.2 Company Description and Business Overview
  • 10.7.3 Sales, Revenue and Market Share of Oxytocic Pharmaceuticals
  • 10.7.4 Oxytocic Pharmaceuticals Product Introduction
  • 10.7.5 Teva Recent Development

11 Value Chain and Sales Channels Analysis

• 11.1 Value Chain Analysis
• 11.2 Sales Channels Analysis
  • 11.2.1 Oxytocic Pharmaceuticals Sales Channels
  • 11.2.2 Oxytocic Pharmaceuticals Distributors
• 11.3 Oxytocic Pharmaceuticals Customers

12 Market Forecast

• 12.1 Global Oxytocic Pharmaceuticals Sales and Revenue Forecast 2019-2025
• 12.2 Global Oxytocic Pharmaceuticals Sales Forecast by Type
• 12.3 Global Oxytocic Pharmaceuticals Sales Forecast by Application
• 12.4 Oxytocic Pharmaceuticals Forecast by Regions
  • 12.4.1 Global Oxytocic Pharmaceuticals Sales Forecast by Regions 2019-2025
  • 12.4.2 Global Oxytocic Pharmaceuticals Revenue Forecast by Regions 2019-2025
• 12.5 United States Market Forecast
• 12.6 European Union Market Forecast
• 12.7 China Market Forecast
• 12.8 Rest of World
  • 12.8.1 Japan
  • 12.8.2 Korea
  • 12.8.3 India

13 Research Findings and Conclusion

14 Appendix

• 14.1 Research Methodology
  • 14.1.1 Methodology/Research Approach
    • 14.1.1.1 Research Programs/Design
    • 14.1.1.2 Market Size Estimation
    • 14.1.1.3 Market Breakdown and Data Triangulation
  • 14.1.2 Data Source
    • 14.1.2.1 Secondary Sources
    • 14.1.2.2 Primary Sources
• 14.2 Author Details

Available under the brand name of Pitocin, the drug oxytocin, which is derived from the peptide of the same name, is commonly used on women during childbirth in order to induce contractions. This can not only increase labor speeds and reduce the time taken for childbirth, but can also cease bleeding after delivery. It is almost always administered to a patient by injecting it into their vein or muscle.
The post-partum haemorrhage segment is expected to register high Y-o-Y growth during the forecast period and is projected to remain the dominant segment during the forecast period.
In 2019, the market size of Oxytocic Pharmaceuticals is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Oxytocic Pharmaceuticals.

This report studies the global market size of Oxytocic Pharmaceuticals, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Oxytocic Pharmaceuticals sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.

In global market, the following companies are covered:
Fresenius Kaci
Biofutura
Baxter
Pfizer
Ferring
Novartis
Teva
...

Market Segment by Product Type
Natural Oxytocin
Synthetic Oxytocin Derivative

Market Segment by Application
Abortion Induced Incomplete
Inevitable Abortion
Post-partum Haemorrhage
Labour Induction
Labour Arrest

Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)

The study objectives are:
To analyze and research the Oxytocic Pharmaceuticals status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Oxytocic Pharmaceuticals manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market

In this study, the years considered to estimate the market size of Oxytocic Pharmaceuticals are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025